Skip to main content

Table 4 Analysis of the relationship between 14-3-3epsilon and Clinical Stages.a

From: 14-3-3epsiloncontributes to tumour suppression in laryngeal carcinoma by affecting apoptosis and invasion

Clinical stages

14-3-3epsilonmRNA

14-3-3epsilon protein

I

1.1288 ± 0.2341

3.0582 ± 0.5554

II

0.9747 ± 0.1976

2.8348 ± 0.5532

III

0.6006 ± 0.1414

1.1029 ± 0.1744

IV

0.9661 ± 0.1609

1.1132 ± 0.1763

p-value

0.342

< 0.001

  1. aGray-scale ratio, mean ± SEM
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us